These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11458337)

  • 1. Fourier transform Raman spectroscopic study of the interaction of water vapor with amorphous polymers.
    Taylor LS; Langkilde FW; Zografi G
    J Pharm Sci; 2001 Jul; 90(7):888-901. PubMed ID: 11458337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of absorbed water on the properties of amorphous mixtures containing sucrose.
    Shamblin SL; Zografi G
    Pharm Res; 1999 Jul; 16(7):1119-24. PubMed ID: 10450941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Water vapor absorption into amorphous sucrose-poly(vinyl pyrrolidone) and trehalose-poly(vinyl pyrrolidone) mixtures.
    Zhang J; Zografi G
    J Pharm Sci; 2001 Sep; 90(9):1375-85. PubMed ID: 11745790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sugar-polymer hydrogen bond interactions in lyophilized amorphous mixtures.
    Taylor LS; Zografi G
    J Pharm Sci; 1998 Dec; 87(12):1615-21. PubMed ID: 10189276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystallization of amorphous solid dispersions of resveratrol during preparation and storage-Impact of different polymers.
    Wegiel LA; Mauer LJ; Edgar KJ; Taylor LS
    J Pharm Sci; 2013 Jan; 102(1):171-84. PubMed ID: 23132686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Water vapor absorption into amorphous hydrophobic drug/poly(vinylpyrrolidone) dispersions.
    Crowley KJ; Zografi G
    J Pharm Sci; 2002 Oct; 91(10):2150-65. PubMed ID: 12226842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrogen Bonding Interactions in Amorphous Indomethacin and Its Amorphous Solid Dispersions with Poly(vinylpyrrolidone) and Poly(vinylpyrrolidone-co-vinyl acetate) Studied Using (13)C Solid-State NMR.
    Yuan X; Xiang TX; Anderson BD; Munson EJ
    Mol Pharm; 2015 Dec; 12(12):4518-28. PubMed ID: 26512737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ability of different polymers to inhibit the crystallization of amorphous felodipine in the presence of moisture.
    Konno H; Taylor LS
    Pharm Res; 2008 Apr; 25(4):969-78. PubMed ID: 17520180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A molecular dynamics simulation of reactant mobility in an amorphous formulation of a peptide in poly(vinylpyrrolidone).
    Xiang TX; Anderson BD
    J Pharm Sci; 2004 Apr; 93(4):855-76. PubMed ID: 14999724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystallization inhibition in solid dispersions of MK-0591 and poly(vinylpyrrolidone) polymers.
    Khougaz K; Clas SD
    J Pharm Sci; 2000 Oct; 89(10):1325-34. PubMed ID: 10980507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical stability of peptides in polymers. 1. Effect of water on peptide deamidation in poly(vinyl alcohol) and poly(vinyl pyrrolidone) matrixes.
    Lai MC; Hageman MJ; Schowen RL; Borchardt RT; Topp EM
    J Pharm Sci; 1999 Oct; 88(10):1073-80. PubMed ID: 10514358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mobility in mixtures of absorbed water and solid poly(vinylpyrrolidone).
    Oksanen CA; Zografi G
    Pharm Res; 1993 Jun; 10(6):791-9. PubMed ID: 8391695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of albendazole crystallization in poly(vinylpyrrolidone) solid molecular dispersions.
    Kalaiselvan R; Mohanta GP; Manna PK; Manavalan R
    Pharmazie; 2006 Jul; 61(7):618-24. PubMed ID: 16889070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of drug-polymer hydrogen bonding interactions on the molecular mobility and physical stability of nifedipine solid dispersions.
    Kothari K; Ragoonanan V; Suryanarayanan R
    Mol Pharm; 2015 Jan; 12(1):162-70. PubMed ID: 25426538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical stability of the amorphous state of loperamide and two fragment molecules in solid dispersions with the polymers PVP-K30 and PVP-VA64.
    Weuts I; Kempen D; Decorte A; Verreck G; Peeters J; Brewster M; Van den Mooter G
    Eur J Pharm Sci; 2005 Jun; 25(2-3):313-20. PubMed ID: 15911228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of temperature and moisture on the miscibility of amorphous dispersions of felodipine and poly(vinyl pyrrolidone).
    Marsac PJ; Rumondor AC; Nivens DE; Kestur US; Stanciu L; Taylor LS
    J Pharm Sci; 2010 Jan; 99(1):169-85. PubMed ID: 19492305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissolution and Solubility Enhancement of the Highly Lipophilic Drug Phenytoin via Interaction with Poly(N-isopropylacrylamide-co-vinylpyrrolidone) Excipients.
    Widanapathirana L; Tale S; Reineke TM
    Mol Pharm; 2015 Jul; 12(7):2537-43. PubMed ID: 26046484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mobility in glassy dispersions.
    Mehta M; McKenna GB; Suryanarayanan R
    J Chem Phys; 2016 May; 144(20):204506. PubMed ID: 27250315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-plasticizing effect of amorphous indomethacin induced by specific intermolecular interactions with PVA copolymer.
    Ueda H; Aikawa S; Kashima Y; Kikuchi J; Ida Y; Tanino T; Kadota K; Tozuka Y
    J Pharm Sci; 2014 Sep; 103(9):2829-2838. PubMed ID: 24890320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Molecular Interactions for Synergistic Precipitation Inhibition of Poorly Soluble Drug in Supersaturated Drug-Polymer-Polymer Ternary Solution.
    Prasad D; Chauhan H; Atef E
    Mol Pharm; 2016 Mar; 13(3):756-65. PubMed ID: 26866895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.